10th Status Seminar Chemical Biology

Poster Programme

P 01 Determination of cadmium speciation uptake by vetiver grass (Vetiveria nemoralis. A.Camus)
K. Jampasri, A. Kumsopa, University of Mahidol, Bangkok/T
P 02 Investigating aglycone maturation in glycopeptide antibiotic biosynthesis
M. Peschke, K. Haslinger, C. Brieke, M.J. Cryle, MPI for Medical Research, Heidelberg/D
P 03 Synthesis and modifications towards Crocapeptin A
C. Wuttke, U. Kazmaier, University of Saarland, Saarbrücken/D
P 04 The structure of CotB2 a bacterial diterpene cyclase is reported. Plasticity residues have been mutated resulting in new, bioactive products
R. Janke, FU Berlin/D; C. Görner, M. Hirte, T. Brück, TU München, Garching/D; B. Loll, FU Berlin/D
P 05 Affinity matrices for chemical proteomics
G. Médard, B. Kuster, University of Munich, Freising/D
P 06 Towards the discovery of a selective EPHA2 inhibitor
S. Heinzlmeir, G. Medard, University of Munich, Freising/D; K. Saxena, H. Schwalbe, University of Frankfurt/D; B. Kuster, University of Munich, Freising/D
P 07 Generic cell-permeable probes of eukaryotic and bacterial sialyl transferases: new targets in inflammation and cancer?
J.J. Preidl, University of Berlin/D; V.S. Gnanapragassam, R. Horsttkorte, University of Halle-Wittenberg/D; J. Rademann, University of Berlin/D
P 08 The biosynthesis of albicidin
D. Petras, A. Mainz, TU Berlin/D; S. Cociancich, M. Royer, CIRAD UMR BGPI, Montpellier/F; R.D. Süssmuth, TU Berlin/D
P 09 Wnt signaling inhibition by withanolide-inspired small molecules:β-catenin on a rollercoaster ride
S. Kapoor, M. Sheremet, S. Sievers, S. Ziegler, K. Kumar, H. Waldmann, Max Planck Institute of Molecular Physiology, Dortmund/D
P 10 Development of a STAT5 inhibitor as potential therapeutic approach for acute Myeloid Leukemia
E. Wong, FU Berlin/D; B. Kim, Leibniz Institut für Molekulare Pharmakologie (FMP), Berlin/D; E. Nawrotzky, C. Arkona, FU Berlin/D; S. Beligny, M. Lisurek, D. Carstanjen, Leibniz Institut für Molekulare Pharmakologie (FMP), Berlin/D; J. Rademann, FU Berlin/D
P 11 Employing the enone functionality to modulate biological activity
N. Al-Rifai, M. Enzinger, A. Rasras, H. Rücker, S. Amslinger, University of Regensburg/D
P 12 Novel, highly selective benzoxazepine-type inhibitors for the CREBBP/EP300 bromodomains
F. Bracher, T.A. Popp, University of Munich/D; O. Fedorov, C. Tallant, S. Knapp, SGC Oxford/UK
P 13 Natural product inspired compound collection emphasizes the MAP4K4 connection to neuritogenesis
P. Schröder, T. Förster, S. Ziegler, K. Kumar, H. Waldmann, Max Planck Institute of Molecular Physiology, Dortmund/D
P 14 Distinct signaling requirements for the establishment of naïve pluripotency in chemical reprogramming of late-stage epiblast stem cells
D.J. Illich, M. Zhang, Max Planck Institute for Molecular Biomedicine, Münster/D; A. Ursu, Max Planck Institute of Molecular Physiology, Dortmund/D; R. Osorno, G. Wu, D. Esch, K. Adachi, D. Sabour, M. Stehling, S. Höing, Max Planck Institute for Molecular Biomedicine, Münster/D; S. Ziegler, H. Waldmann, Max Planck Institute of Molecular Physiology, Dortmund/D; H.R. Schöler, Max Planck Institute for Molecular Biomedicine, Münster/D
P 15 Multivalent DOTAM derivatives for bacteria theranostic applications
H.-Y. Hu, B. Rais, N. Meier, G. Sergeev, P. P. Müller, M. Brönstrup, Helmholtz Center for Infection Research, Braunschweig/D
P 16 The Compound Management and Screening Center of the Max Planck Society (COMAS)
G. Hahne, S. Sievers, Max Planck Institute of Molecular Physiology, Dortmund/D
P 17 Transition-metal-mediated uncaging in living human cells - an emerging alternative to photolabile protecting groups
T. Völker, E. Meggers, Universität Marburg/D
P 18 Total synthesis and absolute configuration of epicoccamide D, a naturally occurring mannosylated 3-acyltetramic acid
S. Loscher, R. Schobert, University of Bayreuth/D
P 19 Multivalent peptide-conjugates to address viral interactions
M. Glanz, Leibniz-Institut für Molekulare Pharmakologie (FMP), Berlin/D; D. Lauster, Humboldt-Universität zu Berlin/D; M. Hellmund, K. Ludwig, C. Böttcher, R. Haag, FU Berlin/D; A. Herrmann, Humboldt-Universität zu Berlin/D; C.P.R. Hackenberger, Leibniz-Institut für Molekulare Pharmakologie (FMP), Berlin/D
P 20 Formation of inhibitors of factor Xa via template-assisted fragment-ligation reactions
M. Jaegle, J. Rademann, FU Berlin/D
P 21 Structural and biochemical characterization of the human soluble adenylyl cyclase
S. Kleinbölting, C. Steegborn, University of Bayreuth/D
P 22 A click-chemistry approach toward JAK3-selective ruxolitinib analogs
M. Gehringer, M. Forster, S. Laufer, University of Tübingen/D
nach oben
Veranstaltungen
Jetzt Mitglied werden